Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study.


Amphotericin B (AmB) use is limited by the occurrence of kidney toxicity. Here, we evaluated the incidence and impact of nephrotoxicity in a large series of patients receiving therapy with amphotericin B deoxycholate (d-AmB), liposomal AmB (L-AmB), or AmB lipid complex (ABLC), in a clinical practice scenario. In a retrospective cohort study, patients… (More)
DOI: 10.1111/myc.12283


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.